From the investor call today, it appears that that rate of cash burn will continue until FDA submission in around 4-8 weeks, then they will scale down costs pending a number of outcomes (revenues, FDA approval, wider regulatory approvals etc).
They're walking a tight line.
I think its pretty clear still that everything turns on FDA. Hopefully approved by July-August.
If FDA obtained I think I'd be fairly relaxed about them raising/sourcing capital and continuing to spend. If no FDA approval its probably fu*t.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
